I saw the CEO on CNBC last night, round 5 pm. He was asked what effect the NON Announcement or NON report on his drug would have on the company, since it was supposed to happen in New Orleans this week. *I only caught part of the report* He said it shouldn't hurt and we can not do a PR because it has to be announced in a forum, like a medical confrence. Bottom Line, he expects good things when he gets to talk, you get the same feeling from that? or did you not see it?
If you guys are refering to the good news I was reporting, all I heard was him say " yes we like reporting at these confrences but, when we get to report people will be happy" He was talking about the drugs but did not say which ones. I think think he was going to report progress but not sure it was a completion for any drug. I hope it is though. BTW the news he was talking about was to be presented in New Orleans last week, pushed back to December this year
gladpick, I think you are correct about the name meerimepodib? I know it was a protease-like inhibitor, taken in conjunction with interferon and riboviron. They are starting 950 trials this fall at the hospital I am being treated. gdubya
<<Bottom Line, he expects good things when he gets to talk, you get the same feeling from that? or did you not see it?>> ----------------------------- I did not see it. But he is correct regarding his preference of announcing results in a conference. Even though the main points of a conference presentation are usually announced in a press release before the markets open, the publicity that it would generate among attending scientists as well analysts also has a positive imact on the stock. If he wants to wait it seems to me the news must be good. If the reults are bad or mediocare they usually do not wait to present it in a confernce.
I think Boger will find another forum before the year end to announce news on merimepodib, the details of the plans for VX-950 phase II study based on FDA and european authorities input, vx-702, and vx-765.
gladpick i am in a clinical study for one of vrtx's drugs. according to my nurse there is a liver conference this fall where the results of many clinical studies will be released. she tells me the results are so far positve for the responses to hep c.